Marker TherapeuticsMRKR
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 32 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings, up 5 from Q3 2024. 7 opened new positions and 3 sold out. The largest holders were Alyeska Investment Group, L.P. ($38.5M), NEA Management Company, LLC ($5.1M) and Blue Owl Capital Holdings LP ($1.7M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $41.5M |
| Exits | 3 | $97K |
All 13F filers, Q3 2024 → Q4 2024: 2,507,558 shares bought and 44,691 shares sold, net +2,462,867 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Alyeska Investment Group, L.P. | 0.14% | New | 915,591 | $38.5M |
| NEA Management Company, LLC | 0.29% | Add +51.7% | 1,625,678 | $5.1M |
| Blue Owl Capital Holdings LP | 0.40% | New | 554,250 | $1.7M |
| Aisling Capital Management LP | 0.36% | Add +3.5% | 325,370 | $1.0M |
| Hudson Bay Capital Management LP | 0.01% | New | 331,670 | $958K |
| Vanguard Group Inc. | 0.00% | No change | 243,122 | $756K |
| LPL Financial LLC | 0.00% | New | 79,730 | $248K |
| Geode Capital Management, LLC | 0.00% | Add +5.8% | 75,680 | $235K |
| Northern Trust Corp. | 0.00% | Add +66.9% | 54,156 | $168K |
| Renaissance Technologies | 0.00% | Add +0.8% | 40,050 | $125K |
| State Street Corp. | 0.00% | No change | 20,948 | $65K |
| Invst, LLC | 0.01% | Add +1.2% | 20,237 | $63K |
| Creative Planning | 0.00% | No change | 17,312 | $54K |
| BlackRock, Inc. | 0.00% | Reduce -12.9% | 16,559 | $51K |
| Engineers Gate Manager LP | 0.00% | New | 16,442 | $51K |
| Millennium Management | 0.00% | New | 16,108 | $50K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -21.6% | 15,900 | $49K |
| Matrix Asset Advisors Inc. | 0.01% | No change | 15,000 | $47K |
| Osaic Holdings, Inc. | 0.00% | Add +20.5% | 8,535 | $27K |
| Bank of America Corp. | 0.00% | Add +23.0% | 3,218 | $10K |
| Riggs Asset Managment Co. Inc. | 0.00% | No change | 1,200 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -16.4% | 1,260 | $4K |
| US Bancorp \de | 0.00% | No change | 839 | $3K |
| Morgan Stanley | 0.00% | Reduce -89.5% | 358 | $1K |
| Wells Fargo & Company | 0.00% | No change | 232 | $722 |
| SBI Securities Co., Ltd. | 0.00% | — | 202 | $628 |
| Group One Trading LLC | 0.00% | No change | 178 | $554 |
| Hilltop National Bank | 0.00% | No change | 73 | $227 |
| JPMorgan Chase & Co. | 0.00% | No change | 38 | $119 |
| BNP Paribas Financial Markets | 0.00% | New | 23 | $72 |
| Versant Capital Management, Inc | 0.00% | No change | 15 | $47 |
| FMR LLC | 0.00% | No change | 12 | $37 |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.